TICKERNERD
Menu
CTEVCTEVHealthcare · Health Information Services

CTEV Stock Forecast: Claritev Corp. Price Predictions for 2026-2027

Last close, 4 Nov 2026
$22
+3.19% on the day

The 5 Wall Street analysts covering Claritev Corp. hold a median 12-month price target of $43 — +98.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 64 of 100 as at 3 Nov 2026 — in the upper half.

Market cap
$355.9M
Ticker Nerd rank
64/ 100
Median analyst target
$43
Analysts covering
5
Revenue$257.5M+6.6% y/y
Operating income$33.0M
Net income−$59.2M
Free cash flow$54.6M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−5.8%
1M
−8.6%
YTD
−49.3%
1Y
−65.5%
From 52W high
−68.7%
From 52W low
+60.9%
$13
$69
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CTEV stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Claritev Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 3 Nov 2026
64/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Revisions
91
Accruals
88
Growth
77
Size
57
Quality
48
Value
40
Issuance
38
Momentum
23
Volatility
9

Revisions (91): Analysts have, on balance, been raising their forecasts.

Volatility (9): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

CTEV stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CTEV, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$20$30$40$50$60$70$80Jan 26Apr 26Jul 26Oct 26CTEVHigh $73Median $43Low $30

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says5 analysts
4 Buy1 Hold0 Sell
Low $30Median $43High $73

The green dot is the last close — the median target sits +98.4% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 5 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
21 Aug 2026BarclaysMaintainsOverweight$28 → $40
12 Aug 2026Wells FargoMaintainsEqual-Weight$22 → $30
12 Aug 2026Wells FargoMaintainsEqual-Weight—
10 Aug 2026Canaccord GenuityMaintainsBuy$37 → $43
10 Aug 2026Canaccord GenuityMaintainsBuy—
10 Aug 2026CitigroupMaintainsBuy—
10 Aug 2026CitigroupMaintainsBuy$40 → $45
21 July 2026Canaccord GenuityMaintainsBuy$32 → $37
21 July 2026Canaccord GenuityMaintainsBuy—
29 May 2026Canaccord GenuityInitiatesBuy—
29 May 2026Canaccord GenuityInitiatesBuy$32
24 Apr 2026BarclaysInitiatesOverweight—
19 Mar 2026Wells FargoMaintainsEqual-Weight—
25 Feb 2026CitigroupMaintainsBuy—
24 Feb 2026GuggenheimMaintainsBuy—
24 Feb 2026Wells FargoMaintainsEqual-Weight—
9 Jan 2026CitigroupMaintainsBuy—
9 Jan 2026Wells FargoInitiatesEqual-Weight—
10 Nov 2025CitigroupMaintainsBuy—
22 Oct 2025CitigroupUpgradeBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

CTEV appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.

Free. Unsubscribe any time.

The AI build-out map
PDF

  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and serversIn full

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

CTEV vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 4 Nov 2026, Claritev Corp. returned −65.5% against +14.8% for the S&P 500, dividends included.

CTEV vs S&P 500, last 12 monthsTotal return, rebased to 100
20406080100120Jan 26Apr 26Jul 26Oct 26CTEVS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CTEV analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
+5.8%
Analysts raising
1
Analysts cutting
0
Fundamentals

Claritev Corp. (CTEV) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−1.2×

Cheaper than 84% of US stocks

Price / sales
0.4×

Cheaper than 86% of US stocks

Price / book
−1.2×

Cheaper than 95% of US stocks

EV / EBITDA
9.4×

Cheaper than 39% of US stocks

Growth & margins
Revenue growth (YoY)
6.6%

Higher than 44% of US stocks

Earnings growth (YoY)
6.6%

Higher than 45% of US stocks

Gross margin
67.3%

Higher than 80% of US stocks

Operating margin
12.8%

Higher than 69% of US stocks

Net margin
−28.5%

Higher than 13% of US stocks

Returns & dividend
Return on equity
170.1%

Higher than 98% of US stocks

Return on assets
1.2%

Higher than 52% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Claritev Corp. (CTEV) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Claritev Corp. has a market value of $355.9M and an enterprise value of $5.1B.

  • Revenue in the twelve months to 30 June 2026: $994.7M. The latest quarter grew 6.6% year on year.

  • Net income over the same four quarters: −$283.1M, a −28.5% net margin.

  • Diluted earnings per share, trailing twelve months: $−17.01.

  • Free cash flow in the twelve months to 30 June 2026: −$17.9M.

  • Shares outstanding: 16.9M.

  • Trailing P/E: −1.2×; forward P/E: 2.9× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Claritev Corp. employs 3,000 people — $332K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 4 Nov 2026

Data provided by Twelve Data

Peers

CTEV vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services
CompanyMarket capTKN rank
CTEVClaritev Corp.$355.9M64
CARLCarlsmed, Inc.$391.5M—
EVHEvolent Health, Inc.$480.0M—
SPOKSpok Holdings, Inc.$247.2M76
NRCNRC Health$542.5M88
SOPHSOPHiA GENETICS SA$579.7M—
WEAVWeave Communications, Inc.$592.0M—

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Claritev Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CTEV news & analysis

Claritev Introduces Transparency-Based Pricing, Turning Complex Public Market Data into Actionable Reimbursement Intelligence

GlobeNewsWire · 29 Oct 2026positive

Claritev announced the launch of Transparency-Based Pricing, a market-informed reimbursement intelligence solution for payers and third-party administrators. The company says it is designed to provide greater flexibility and confidence in managing healthcare costs and reimbursement strategies.

Why it matters — The launch adds a new reimbursement intelligence offering to Claritev’s healthcare technology, data, and insights portfolio.

Claritev Corporation (CTEV) Surges 5.2%: Is This an Indication of Further Gains?

Zacks Investment Research · 28 Oct 2026neutral

Claritev Corporation (CTEV) rose 5.2% in the latest session on higher-than-average trading volume. The article notes that recent earnings estimate revision trends may not support further near-term gains.

Why it matters — CTEV watchers may note both the share-price move and the article’s caution about earnings estimate revisions.

Claritev Appoints Jennifer Main to its Board of Directors

GlobeNewsWire · 15 Oct 2026neutral

Claritev announced that its Board of Directors appointed Jennifer (Jenni) Main as a director, effective October 15, 2026. The appointment fills a newly created board seat.

Why it matters — CTEV watchers may note the addition of a director to Claritev’s Board.

Claritev Corporation Announces Third Quarter 2026 Earnings Conference Call

GlobeNewsWire · 14 Oct 2026neutral

Claritev said it will release its third-quarter fiscal 2026 financial results before market open on November 9, 2026, and hold a conference call at 8:00 a.m. Eastern Time that day.

Why it matters — CTEV watchers can note the date and time when the company plans to report its quarterly results and discuss them on a call.

Claritev: Revenue Growth Is Back, Cash Flow Is The Next Test

Seeking Alpha · 6 Oct 2026neutral

Seeking Alpha reports early signs of a turnaround at Claritev, with revenue and bookings growth, though growth is concentrated in Claims Intelligence. The article highlights high leverage, modest projected 2026 free cash flow, and the need for broader margin recovery and operational leverage.

Why it matters — CTEV watchers are monitoring whether revenue growth can translate into stronger cash flow and broader operating improvement amid substantial debt.

FAQ

Frequently asked questions about CTEV stock

What is the CTEV stock price forecast for 2026-2027?

The 5 Wall Street analysts covering Claritev Corp. have a median 12-month price target of $43, with estimates ranging from $30 to $73. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CTEV stock a buy right now?

Of the 5 analysts covering Claritev Corp., 4 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Claritev Corp. 64 out of 100 across roughly 4,600 US stocks as at 3 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CTEV?

As at 3 Nov 2026, Claritev Corp. ranks 64 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (91 of 100).

Will CTEV stock go up?

No one can know that. What the data says: the median 12-month target from 5 analysts implies +98.4% from the last close, and Ticker Nerd's factor model ranks Claritev Corp. 64 out of 100 as at 3 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CTEV stock forecast for 2030?

No analyst covering Claritev Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CTEV are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $30 to $73 over the next 12 months.

How has CTEV stock performed over the past year?

Claritev Corp. returned -65.5% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Claritev Corp. do?

Claritev Corp. Class A Common Stock is the equity security of Claritev Corporation, a healthcare technology and data services company focused on cost management, payment integrity, and revenue integrity solutions for the U.S.

What is the latest news on CTEV?

The most recent item we track (GlobeNewsWire, 29 Oct 2026): "Claritev Introduces Transparency-Based Pricing, Turning Complex Public Market Data into Actionable Reimbursement Intelligence". Claritev announced the launch of Transparency-Based Pricing, a market-informed reimbursement intelligence solution for payers and third-party administrators. The company says it is designed to provide greater flexibility and confidence in managing healthcare costs and reimbursement strategies.

Company

About Claritev Corp.

Claritev Corp. Class A Common Stock is the equity security of Claritev Corporation, a healthcare technology and data services company focused on cost management, payment integrity, and revenue integrity solutions for the U.S. healthcare industry. The company supports health plans, providers, and other healthcare stakeholders with data analytics and technology-enabled services designed to improve claims processing, network management, and payment accuracy. Its offerings include claims intelligence, reference-based pricing, negotiation services, surprise bill services, network solutions, and pre- and post-payment integrity tools. Claritev also provides clinical negotiation and revenue integrity services that help clients manage complex healthcare transactions and administrative workflows. Headquartered in McLean, Virginia, Claritev Corp. Class A Common Stock represents ownership in a business that plays a specialized role in healthcare infrastructure by helping organizations manage cost, transparency, and claims-related processes.

CEO Mr. Travis S. Dalton · 3,000 employees · United States · https://www.claritev.com